HCPCS Level IIdrugActive
J1740
Ibandronate sodium injection
BETOS: O1E
Effective: 2024-01-01
Referenced in 4 policies
Description
Injection, ibandronate sodium, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Ibandronate Sodium
Manufacturer
Sagent Pharmaceuticals
HCPCS Dosage
1 MG
Billing Units
3.0000
4
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.